212 related articles for article (PubMed ID: 26705026)
21. A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease.
Ikeda A; Matsushima T; Daida K; Nakajima S; Conedera S; Li Y; Yoshino H; Oyama G; Funayama M; Nishioka K; Hattori N
Parkinsonism Relat Disord; 2017 Jan; 34():66-68. PubMed ID: 28341223
[No Abstract] [Full Text] [Related]
22. Brain glucose metabolism changes in Parkinson's disease patients with CHCHD2 mutation based on (18)F-FDG PET imaging.
Mao CY; Wu P; Zhang SY; Yang J; Liu YT; Zuo CT; Zhuang ZP; Shi CH; Xu YM
J Neurol Sci; 2016 Oct; 369():303-305. PubMed ID: 27653913
[No Abstract] [Full Text] [Related]
23. The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.
Xiong WX; Sun YM; Guan RY; Luo SS; Chen C; An Y; Wang J; Wu JJ
J Neurol; 2016 Oct; 263(10):1984-92. PubMed ID: 27393118
[TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of CHCHD2 in Chinese patients with multiple system atrophy and amyotrophic lateral sclerosis.
Yang X; An R; Zhao Q; Zheng J; Tian S; Chen Y; Xu Y
J Neurol Sci; 2016 Sep; 368():389-91. PubMed ID: 27538669
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy.
Rubino E; Zhang M; Mongini T; Boschi S; Vercelli L; Vacca A; Govone F; Gai A; Giordana MT; Grinberg M; Rogaeva E; Rainero I
Neurobiol Aging; 2018 Jun; 66():181.e1-181.e2. PubMed ID: 29519717
[TBL] [Abstract][Full Text] [Related]
26. Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.
Pchelina SN; Yakimovskii AF; Emelyanov AK; Ivanova ON; Schwarzman AL; Singleton AB
Eur J Neurol; 2008 Jul; 15(7):692-6. PubMed ID: 18435766
[TBL] [Abstract][Full Text] [Related]
27. The mutation spectrum of Parkinson-disease-related genes in early-onset Parkinson's disease in ethnic Chinese.
Chen YP; Yu SH; Zhang GH; Hou YB; Gu XJ; Ou RW; Shen Y; Song W; Chen XP; Zhao B; Cao B; Zhang LY; Sun MM; Liu FF; Wei QQ; Liu KC; Lin JY; Yang TM; Yang J; Wu Y; Jiang Z; Liu J; Cheng YF; Xiao Y; Su WM; Feng F; Cai YY; Li SR; Hu T; Yuan XQ; Zhou QQ; Shao N; Ma S; Shang HF
Eur J Neurol; 2022 Nov; 29(11):3218-3228. PubMed ID: 35861376
[TBL] [Abstract][Full Text] [Related]
28. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
[TBL] [Abstract][Full Text] [Related]
29. EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts.
Huttenlocher J; Krüger R; Capetian P; Lohmann K; Brockmann K; Csoti I; Klein C; Berg D; Gasser T; Bonin M; Riess O; Bauer P
J Med Genet; 2015 Jan; 52(1):37-41. PubMed ID: 25368108
[TBL] [Abstract][Full Text] [Related]
30. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
[TBL] [Abstract][Full Text] [Related]
31. Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson's Disease.
Chen YP; Gu XJ; Ou RW; Zhang LY; Hou YB; Liu KC; Cao B; Wei QQ; Song W; Zhao B; Wu Y; Cheng JQ; Shang HF
Mol Neurobiol; 2021 Apr; 58(4):1583-1592. PubMed ID: 33219486
[TBL] [Abstract][Full Text] [Related]
32. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.
Xiromerisiou G; Hadjigeorgiou GM; Gourbali V; Johnson J; Papakonstantinou I; Papadimitriou A; Singleton AB
Eur J Neurol; 2007 Jan; 14(1):7-11. PubMed ID: 17222106
[TBL] [Abstract][Full Text] [Related]
33. Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
Liu X; Jiao B; Zhang W; Xiao T; Hou L; Pan C; Tang B; Shen L
Mol Med Rep; 2018 Jul; 18(1):461-466. PubMed ID: 29749507
[TBL] [Abstract][Full Text] [Related]
34. New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
Puschmann A
Curr Neurol Neurosci Rep; 2017 Sep; 17(9):66. PubMed ID: 28733970
[TBL] [Abstract][Full Text] [Related]
35. TMEM230 Mutations Are Rare in Han Chinese Patients with Autosomal Dominant Parkinson's Disease.
Wei Q; Ou R; Zhou Q; Chen Y; Cao B; Gu X; Zhao B; Wu Y; Song W; Shang HF
Mol Neurobiol; 2018 Apr; 55(4):2851-2855. PubMed ID: 28455698
[TBL] [Abstract][Full Text] [Related]
36. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.
Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N
Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937
[TBL] [Abstract][Full Text] [Related]
37. Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography.
Im JH; Chung SJ; Kim JS; Lee MC
J Neurol Sci; 2006 May; 244(1-2):103-9. PubMed ID: 16473371
[TBL] [Abstract][Full Text] [Related]
38. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
Adams JR; van Netten H; Schulzer M; Mak E; Mckenzie J; Strongosky A; Sossi V; Ruth TJ; Lee CS; Farrer M; Gasser T; Uitti RJ; Calne DB; Wszolek ZK; Stoessl AJ
Brain; 2005 Dec; 128(Pt 12):2777-85. PubMed ID: 16081470
[TBL] [Abstract][Full Text] [Related]
39. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
[TBL] [Abstract][Full Text] [Related]
40. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J
Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
